# Evaluation of the Impact of the Modification of Antibiotic Susceptibility Testing on Antibiotic Prescriptions

> **NCT05902299** · — · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 199 (estimated)

## Conditions studied

- Antibiotic Resistant Infection

## Interventions

- **DRUG:** Antibiotic

## Key facts

- **NCT ID:** NCT05902299
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-15
- **Primary completion:** 2023-05-16
- **Final completion:** 2023-07-03
- **Target enrollment:** 199 (ESTIMATED)
- **Last updated:** 2023-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05902299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05902299, "Evaluation of the Impact of the Modification of Antibiotic Susceptibility Testing on Antibiotic Prescriptions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05902299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*